Biogen

Biotechnology

Biogen is a biotechnology company specializing in neurology and neurodegeneration, with leading therapies for multiple sclerosis and spinal muscular atrophy. The company's controversial Alzheimer's drug Aduhelm sparked debates about FDA approval standards and drug pricing. Biogen continues to invest heavily in neuroscience research and biosimilars.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me